Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

10(100.0%)

10Total

N/A(10)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06990152Not ApplicableCompleted

A Randomized, Double-blind Clinical Trial on the Efficacy of a Dietary Formulation Containing Medium-chain Triglycerides (MCT) and Fiber in Patients With Psoriatic Arthritis

Role: lead

NCT07505277Not ApplicableRecruiting

Study of the Effects of Food Formulations Containing Antioxidants, Prebiotic Fibers, and Oat Beta-glucans in Individuals at Risk of Metabolic Syndrome

Role: lead

NCT06951932Not ApplicableRecruiting

Evaluation of the Impact of Medium-chain Fatty Acids in the Evolution of Newly Diagnosed Mild Cognitive Impairment

Role: collaborator

NCT05489120Not ApplicableRecruiting

Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD)

Role: lead

NCT04519827Not ApplicableCompleted

A Hypoallergenicity Study on a New Rice-Based Hydrolysate Formula

Role: lead

NCT04400422Not ApplicableCompleted

Experience of Using Lipano in Children With Fatty Acid Oxidation Disorders